Medical network - on April 11, recently, the national development and reform commission website issued a "shenzhen city health development planning commission promised to correct in the pilot reform of public hospital drug group procurement abuse administrative power ruled out restrict competition behavior, a widespread social concern is caused. 10, the city health development planning commission, shenzhen pilot reform of public hospital pharmaceutical group purchasing has carried out three rectification. 

 

Shenzhen corrective recognised by the team 

 

According to the city health development planning commission, in July 2016, shenzhen according to the requirements of relevant national, provincial reform start pilot reform of public hospital pharmaceutical group purchasing. The purpose of reform is to reduce drug prices as deepening health reform breakthrough, in the protection of clinical medication requirements, and under the premise of drug quality, further reducing drug purchase cost, to make room for the reform of medical service prices. Period, the national development and reform commission (hereinafter referred to as the panel) investigators to supervision of related work, put forward rectification opinions and requirements. In December 2016, the shenzhen city health development planning commission by the national development and reform commission of guangdong province shall be submitted to the team the rectification report, improvement ideas and measures to get the recognition of the team, has now completed the following corrective actions: 

 

(a) to ensure that public hospital drug procurement autonomy. Choice of drug purchase platform not mandatory restrictions, allowing the 25 public hospital according to the actual need, drug prices and other factors to choose its own entrust existing group purchasing organization (i.e., the whole network pharmaceutical) or purchasing platform in the southern province of guangdong, expansion of procurement channels, promote the market competition. 

 

(2) make sure choose autonomy drug distribution enterprises. Drug distribution enterprises no longer by the drug group purchasing organization (hereinafter referred to as the GPO) unilaterally specified. Entrust the GPO purchasing medicines, its distribution process is adjusted for: 1. The pharmaceutical production enterprise from GPO selection for drug distribution enterprises, choose a number of commissioned distribution companies, public hospitals can choose; 2. Public hospitals can choose one according to each product gauge the principle of distribution enterprises, choose 1, commissioned distribution relationships. 

 

(3) to ensure that the pharmaceutical production enterprise autonomy. Allow the pharmaceutical producing enterprises to choose its own existing group purchasing organization or other drug procurement platform to the public hospital of shenzhen sales directory. 

 

On February 17, 2017, the shenzhen health development planning commission published the "about perfecting public hospital drug procurement and distribution of the group of notice (deep who plan hair [2017] no.5) and the related corrective actions shall be clear and the documents have been executed. 

 

The reform of drug purchase was pushing 

 

According to the city health development planning commission, according to the requirements of the "rectification and improvement", shenzhen pilot reform of public hospital pharmaceutical group purchasing follow-up work is orderly progress. At present, the first batch of group procurement directory with a shortage of medicine, low price guarantee clinical application such as medicine, pediatric medicine mainly 403 drugs have completed sourcing and start to supply. The second batch of group procurement directory based on Chinese medicines, chemical medicine, biological products, as well as infusion drugs mainly bargaining work was completed in recent talks, the expert review identify suppliers and carry on the public. 

 

In order to avoid "low prices", after the reform package, shenzhen health development planning commission organized experts in clinical and pharmaceutical, etc, make the group purchasing drugs directory, drug quality level classification rules, the integration of pharmaceutical dosage forms, such as operating conditions, in accordance with the "evaluation of the quality first, more than the price, supply" principle, the citizens of both shenzhen and clinical medical institutions custom custom, selected high quality and low price of drugs. 

 

Shenzhen will continue to improve the drug group purchase mode 

 

City health development planning commission, said the national development and reform commission (NDRC), the national development and reform commission of guangdong province and the superior under the supervision of the competent administrative department of public health, shenzhen revision will continue to improve the system of drug group procurement reform design and relevant rules, perfecting fits a pattern of drug group procurement rules of market operation, and make it conform to the "anti-monopoly law" and "about to establish fair competition in the market system construction's opinions on censorship (guo fa [2016] no. 34) regulation, promoting drug group procurement model of normative and orderly development. At the same time, shenzhen will support and guide qualified pharmaceutical enterprises or other organizations develop GPO, makes the reform more conform to the principle of fair competition in the market. 

 

Drugs during the pilot reform of group purchase, shenzhen will progress in a timely manner to the public and related matters, voluntarily accept supervision from all walks of life.